Fundz

Bio-Techne Announces Changes to Its Leadership Team

PUBLIC · TECHFeb 11, 2026

Position

President

Company

Bio-Techne Corporation

Matt McManus
MinneapolisManufacturingBiotechnologyHealth CareScience And EngineeringBiotechnology Research

Description

Bio-Techne Corporation (NASDAQ: TECH) announced that Dr Matt McManus, President of its Diagnostics and Spatial Biology Segment, will transition from his role effective March 1, 2026. He will remain with the company for a period of time to support a smooth transition. Bio-Techne has appointed Steve Crouse, currently Senior Vice President of the Analytical Solutions Division, as President of the Diagnostics and Spatial Biology Segment.

Other recent leadership changes in Science And Engineering and Biotechnology Research

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Bio-Techne Corporation, and when

A new leader at Bio-Techne Corporation brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Bio-Techne Corporation raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Bio-Techne Corporation, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Bio-Techne Corporation. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Bio-Techne Corporation

Location

Minneapolis, Minnesota, United States

About

Bio-Techne Corporation is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. They design and manufacture products that enable researchers and healthcare professionals to improve patients' lives. Bio-Techne partners with Wilson Wolf to create tailored products for G-Rex® Bioreactors, focusing on high throughput closed-system manufacturing.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Bio-Techne Corporation changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Bill
Likely contact at this company
••••••••@••••••••

See Bill's verified email →

Sophia
Likely contact at this company
••••••••@••••••••

See Sophia's verified email →

Matthew
Likely contact at this company
••••••••@••••••••

See Matthew's verified email →

Adrian
Likely contact at this company
••••••••@••••••••

See Adrian's verified email →

Jim
Likely contact at this company
••••••••@••••••••

See Jim's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Bio-Techne Corporation's next move

Learn about Strategic plan

Bio-Techne Corporation changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.